Landry Robert E's Form 4 filing
Regeneron Pharmaceuticals, Inc.REGN · filed Mar 29, 2023
- Accession no.
- 0001968202-23-000004
- Filed
- Mar 29, 2023
- Trade date
- Mar 27-28, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 20 non-derivative transactions and 2 derivative transactions. Open-market sales total $979.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Landry Robert ECIK 0001585160 | Officer (EVP Finance CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Common Stock | MOption exerciseAcquired | +800 | $381.92 | +$305,536 | 32,905 | Direct | |
| Mar 27, 2023 | Common Stock | FTax withholdingDisposed | −589 | $825.17 | −$486,025.13 | 32,316 | Direct | |
| Mar 27, 2023 | Common Stock | MOption exerciseAcquired | +3,000 | $378.98 | +$1,136,940 | 35,316 | Direct | |
| Mar 27, 2023 | Common Stock | FTax withholdingDisposed | −2,204 | $825.17 | −$1,818,674.68 | 33,112 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −39 | $819.47F2 | −$31,959.33 | 33,073 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −50 | $820.46F3 | −$41,023 | 33,023 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −48 | $821.39F4 | −$39,426.72 | 32,975 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −18 | $822.57F5 | −$14,806.26 | 32,957 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −4 | $824.30 | −$3,297.2 | 32,953 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −13 | $825.59 | −$10,732.67 | 32,940 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −4 | $829.16 | −$3,316.64 | 32,936 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −7 | $830.01 | −$5,810.07 | 32,929 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −10 | $818.81 | −$8,188.1 | 32,919 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −115 | $820.85F6 | −$94,397.75 | 32,804 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −142 | $821.40F7 | −$116,638.8 | 32,662 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −128 | $822.67F8 | −$105,301.76 | 32,534 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −181 | $823.60F9 | −$149,071.6 | 32,353 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −157 | $824.54F10 | −$129,452.78 | 32,196 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −243 | $825.37F11 | −$200,564.91 | 31,953 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −31 | $826.36 | −$25,617.16 | 31,922 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 20,337 | Direct | |
| Mar 27, 2023 | Common Stock | MOption exerciseDisposed | −800 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 39 shares of Company stock on March 27, 2023 at prices ranging from $819.34 to $819.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 50 shares of Company stock on March 27, 2023 at prices ranging from $820.00 to $820.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 48 shares of Company stock on March 27, 2023 at prices ranging from $821.02 to $821.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 18 shares of Company stock on March 27, 2023 at prices ranging from $822.46 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 115 shares of Company stock on March 28, 2023 at prices ranging from $820.67 to $820.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 142 shares of Company stock on March 28, 2023 at prices ranging from $821.04 to $821.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 128 shares of Company stock on March 28, 2023 at prices ranging from $822.21 to $822.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 181 shares of Company stock on March 28, 2023 at prices ranging from $823.02 to $823.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 157 shares of Company stock on March 28, 2023 at prices ranging from $824.00 to $824.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F11
Represents volume-weighted average price of sales of 243 shares of Company stock on March 28, 2023 at prices ranging from $825.02 to $825.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.